Keskin, Z. Et Al. 2021. Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line. 2. International Cancer Days , (Sivas, Turkey), 136.

Keskin, Z., Yulak, F., & Terzi, H., (2021). Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line . 2. International Cancer Days (pp.136). Sivas, Turkey

Keskin, ZEKERİYA, FATİH YULAK, And HATİCE TERZİ. "Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line," 2. International Cancer Days, Sivas, Turkey, 2021

Keskin, ZEKERİYA Et Al. "Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line." 2. International Cancer Days , Sivas, Turkey, pp.136, 2021

Keskin, Z. Yulak, F. And Terzi, H. (2021) . "Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line." 2. International Cancer Days , Sivas, Turkey, p.136.

@conferencepaper{conferencepaper, author={ZEKERİYA KESKİN Et Al. }, title={Evaluation of the Antitumoral Efficacy of Ibrutinib on Burkitt Lymphoma Cell Line}, congress name={2. International Cancer Days}, city={Sivas}, country={Turkey}, year={2021}, pages={136} }